Pyroxamide is a potent small molecule inhibitor of histone deacetylases (HDACs), particularly HDAC1 (IC50: 0.1-0.2 µM), exhibiting antineoplastic activity. It is widely used in cancer research to study epigenetic mechanisms, demonstrating effects in both cellular assays and in vivo tumor models.